APA (7th ed.) Citation

Wang, P., Yu, S., Chen, X., Zheng, X., Mao, J., Jing, H., . . . Su, X. (2026). [18F]MFBG PET/CT is an effective and preferable imaging modality for neuroblastoma in a prospective comparison with SSTR PET. European Journal of Nuclear Medicine & Molecular Imaging, 53(2), 899. https://doi.org/10.1007/s00259-025-07449-y

Chicago Style (17th ed.) Citation

Wang, Peipei, Sun Yu, Xiaorui Chen, Xinyue Zheng, Junqing Mao, Hongli Jing, Hongming Zhuang, Fang Li, and Xinhui Su. "[18F]MFBG PET/CT Is an Effective and Preferable Imaging Modality for Neuroblastoma in a Prospective Comparison with SSTR PET." European Journal of Nuclear Medicine & Molecular Imaging 53, no. 2 (2026): 899. https://doi.org/10.1007/s00259-025-07449-y.

MLA (9th ed.) Citation

Wang, Peipei, et al. "[18F]MFBG PET/CT Is an Effective and Preferable Imaging Modality for Neuroblastoma in a Prospective Comparison with SSTR PET." European Journal of Nuclear Medicine & Molecular Imaging, vol. 53, no. 2, 2026, p. 899, https://doi.org/10.1007/s00259-025-07449-y.